What is the equity of ViewRay this year?
ViewRay has equity of 82.2 M USD this year.
ViewRay Equity 2024
ViewRay Equity
82.2 M USD
Ticker
VRAYQ
ISIN
US92672L1070
WKN
A2AE2S
In 2024, ViewRay's equity was 82.2 M USD, a -51.59% increase from the 169.8 M USD equity in the previous year.
ViewRay Aktienanalyse
What does ViewRay do?
ViewRay Inc. is an American medical technology company based in Cleveland, Ohio. It was founded in 2004 by Ivor Jankovic and specializes in the manufacturing of radiation therapy devices. The history of ViewRay begins with the idea of developing innovative technology to treat cancer patients more effectively and gently. In 2005, the company entered into an agreement with the Cleveland Clinic Lerner Research Institute to conduct research on a novel magnetic resonance-guided radiation therapy machine. The research project was led by James F. Dempsey, Chair of the Department of Radiation Oncology at the Cleveland Clinic. In 2009, the first magnetic resonance-guided radiation therapy system was delivered and implemented at the Cleveland Clinic. ViewRay's business model is based on the development and manufacturing of innovative medical devices aimed at making the treatment of cancer patients more effective and gentle. The company focuses on combining magnetic resonance imaging (MRI) and radiation therapy to ensure more precise and safer treatment. ViewRay offers various products, including the MRIdian-Linac system, an advanced radiation therapy device that utilizes MRI technology to provide real-time images of the tumor during radiation. This allows for precise targeting of the tumor while sparing the surrounding tissue. The system also offers the ability to sync radiation therapy with the patient's breathing cycle, further improving the accuracy and effectiveness of the treatment. In addition to the MRIdian-Linac system, ViewRay also offers the MRIdian-MRI system, which is solely dedicated to imaging. The MRIdian-MRI is a diagnostic instrument that allows for better visualization of tissue and tumor studies. The system uses the same MRI technology as the MRIdian-Linac to generate radiation-free images. ViewRay has also specialized in the development of software tools that assist doctors in better planning and monitoring radiation therapy. This includes the RayCare Oncology Information System, which provides a comprehensive workflow and management platform, as well as the RayStation Treatment Planning Software, which enables more precise radiation therapy planning. In terms of market reach, ViewRay has a global presence. The company has a strong presence in North America, Europe, and Asia, and works closely with leading research institutes and hospitals to evaluate and improve the effectiveness and efficiency of its technologies. Overall, ViewRay has developed an innovative and unique portfolio of products and solutions that improve radiation therapy and increase accuracy and safety for patients and doctors. The company is a leader in the development of MRI-guided radiation therapy systems and is expected to continue playing a significant role in the medical technology industry in the future. ViewRay ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing ViewRay's Equity
ViewRay's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding ViewRay's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating ViewRay's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
ViewRay's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in ViewRay’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about ViewRay Stock
What was the equity of ViewRay compared to the previous year?
The equity of ViewRay has increased/decreased by -51.59% decreased compared to the previous year.
What impact does a high equity have on investors of ViewRay?
A high equity is advantageous for investors of ViewRay as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of ViewRay?
A low equity can be a risk for investors of ViewRay, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of ViewRay affect the company?
An increase in equity of ViewRay can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of ViewRay affect the company?
A reduction in equity of ViewRay can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of ViewRay?
Some factors that can affect the equity of ViewRay include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of ViewRay so important for investors?
The equity of ViewRay is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can ViewRay take to change the equity?
To change equity, ViewRay can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does ViewRay pay?
Over the past 12 months, ViewRay paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ViewRay is expected to pay a dividend of 0 USD.
What is the dividend yield of ViewRay?
The current dividend yield of ViewRay is .
When does ViewRay pay dividends?
ViewRay pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of ViewRay?
ViewRay paid dividends every year for the past 0 years.
What is the dividend of ViewRay?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is ViewRay located?
ViewRay is assigned to the 'Health' sector.
Wann musste ich die Aktien von ViewRay kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of ViewRay from 6/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/20/2024.
When did ViewRay pay the last dividend?
The last dividend was paid out on 6/20/2024.
What was the dividend of ViewRay in the year 2023?
In the year 2023, ViewRay distributed 0 USD as dividends.
In which currency does ViewRay pay out the dividend?
The dividends of ViewRay are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The ViewRay stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von ViewRay
Our stock analysis for ViewRay Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ViewRay Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.